Home LiteratureArticle Details
PMID: 12714521 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Homeostatic control of T-cell generation in neonates.

Blood ·Vol. 102 ·No. 4 ·2003-08-15 ·Pages 1428-34

Schönland SO, Zimmer JK, Lopez-Benitez CM, Widmann T, Ramin KD, Goronzy JJ, Weyand CM

Abstract

T cells are produced through 2 mechanisms, thymopoiesis and proliferative expansion of postthymic T cells. Thymic output generates diversity of the pool, and proliferation achieves optimal clonal size of each individual T cell. To determine the contribution of these 2 mechanisms to the formation of the initial T-cell repertoire, we examined neonates of 30 to 40 weeks' gestation. Peripheral T cells were in a state of high proliferative turnover. In premature infants, 10% of T cells were dividing; the proliferation rates then declined but were still elevated in mature newborns. Throughout the third trimester, concentrations of T-cell-receptor excision circles (TRECs) were 10 per 100 T cells. Stability of TREC frequencies throughout the period of repertoire generation suggested strict regulation of clonal size to approximately 10 to 20 cells. Neonatal naive CD4+ and CD8+ T cells were explicitly responsive to IL-7; growth-promoting properties of IL-15 were selective for newborn CD8+ T cells. Neonatal T cells expressed telomerase and, in spite of the high turnover, built up a telomeric reserve. Thus, proliferative expansion, facilitated by increased cytokine responsiveness, and thymopoiesis complement each other as mechanisms of T-cell production in neonates. Maintaining optimal clonal size instead of filling the space in a lymphopenic host appears to regulate homeostatic T-cell proliferation during fetal development.

MeSH Terms
Adult CD4-Positive T-Lymphocytes/metabolism CD8-Positive T-Lymphocytes/metabolism Cell Division/immunology,physiology Cells, Cultured Female Fetal Blood/cytology,immunology Hematopoiesis, Extramedullary Homeostasis Humans Infant, Newborn/blood,immunology Insulin-Like Growth Factor I/pharmacology Interleukin-15/biosynthesis,pharmacology Interleukin-7/biosynthesis,pharmacology Lymphocyte Activation/immunology,physiology Male T-Lymphocytes/cytology,immunology,metabolism Telomerase/biosynthesis
Chemicals
Interleukin-15 Interleukin-7 Insulin-Like Growth Factor I Telomerase
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Schönland Stefan O
Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Zimmer Julia K
Lopez-Benitez Consuelo M
Widmann Thomas
Ramin Kirk D
Goronzy Jörg J
Weyand Cornelia M
Article Info
Journal
Blood
Abbr.
Blood
ISSN
0006-4971
Published
2003-08-15
Epub
2003-00-24
Pages
1428-34
Language
English
Region
United States
NLM ID
7603509
Subset
IM
Grants
NIA NIH HHS · R01 AG15043 · United States
NIAMS NIH HHS · R01 AR41974 · United States
NIAMS NIH HHS · R01 AR42527 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com